• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在载有结晶性难溶性药物的长丝的熔融沉积成型3D打印过程中,通过融合辅助非晶化实现增强的过饱和度。

Enhanced Supersaturation via Fusion-Assisted Amorphization during FDM 3D Printing of Crystalline Poorly Soluble Drug Loaded Filaments.

作者信息

Buyukgoz Guluzar Gorkem, Kossor Christopher Gordon, Davé Rajesh N

机构信息

Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, NJ 07102, USA.

出版信息

Pharmaceutics. 2021 Nov 4;13(11):1857. doi: 10.3390/pharmaceutics13111857.

DOI:10.3390/pharmaceutics13111857
PMID:34834272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8618474/
Abstract

Filaments loaded with griseofulvin (GF), a model poorly water-soluble drug, were prepared and used for 3D printing via fused deposition modeling (FDM). GF was selected due to its high melting temperature, enabling lower temperature hot-melt extrusion (HME) keeping GF largely crystalline in the filaments, which could help mitigate the disadvantages of high HME processing temperatures such as filament quality, important for printability and the adverse effects of GF recrystallization on tablet properties. Novel aspects include single-step fusion-assisted ASDs generation during FDM 3D printing and examining the impact of tablet surface areas (SA) through printing multi-mini and square-pattern perforated tablets to further enhance drug supersaturation during dissolution. Kollicoat protect and hydroxypropyl cellulose were selected due to their low miscibility with GF, necessary to produce crystalline filaments. The drug solid-state was assessed via XRPD, DSC and FT-IR. At 165 °C HME processing temperature, the filaments containing ~80% crystalline GF were printable. Fusion-assisted 3D printing led to GF supersaturation of ~153% for cylindrical tablets and ~293% with the square-pattern perforated tablets, indicating strong monotonous impact of tablet SA. Dissolution kinetics of drug release profiles indicated Fickian transport for tablets with higher SA, demonstrating greater SA-induced drug supersaturation for well-designed 3D printed tablets.

摘要

制备了负载有灰黄霉素(GF,一种难溶性药物模型)的长丝,并通过熔融沉积建模(FDM)用于3D打印。选择GF是因为其熔点高,能够在较低温度下进行热熔挤出(HME),使GF在长丝中基本保持结晶状态,这有助于减轻HME加工温度过高带来的缺点,如长丝质量问题(这对可打印性很重要)以及GF重结晶对片剂性质的不利影响。新的方面包括在FDM 3D打印过程中一步法生成融合辅助无定形固体分散体(ASD),以及通过打印多种微型和方形图案的多孔片剂来研究片剂表面积(SA)的影响,以进一步提高溶解过程中的药物过饱和度。选择了Kollicoat protect和羟丙基纤维素,因为它们与GF的低混溶性是生产结晶长丝所必需的。通过X射线粉末衍射(XRPD)、差示扫描量热法(DSC)和傅里叶变换红外光谱(FT-IR)对药物固态进行了评估。在165℃的HME加工温度下,含有约80%结晶GF的长丝是可打印的。融合辅助3D打印使圆柱形片剂的GF过饱和度达到约153%,方形图案多孔片剂的过饱和度达到约293%,表明片剂SA有强烈的单调影响。药物释放曲线的溶解动力学表明,表面积较大的片剂为菲克扩散,这表明精心设计的3D打印片剂具有更大的SA诱导药物过饱和度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/f97732426876/pharmaceutics-13-01857-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/582cdf626d74/pharmaceutics-13-01857-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/4d385be7db72/pharmaceutics-13-01857-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/7cf0e0a2dcff/pharmaceutics-13-01857-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/75eafd8790ed/pharmaceutics-13-01857-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/f2f2c98222c7/pharmaceutics-13-01857-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/afa17ffe98ec/pharmaceutics-13-01857-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/f97732426876/pharmaceutics-13-01857-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/582cdf626d74/pharmaceutics-13-01857-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/4d385be7db72/pharmaceutics-13-01857-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/7cf0e0a2dcff/pharmaceutics-13-01857-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/75eafd8790ed/pharmaceutics-13-01857-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/f2f2c98222c7/pharmaceutics-13-01857-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/afa17ffe98ec/pharmaceutics-13-01857-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fbf/8618474/f97732426876/pharmaceutics-13-01857-g007.jpg

相似文献

1
Enhanced Supersaturation via Fusion-Assisted Amorphization during FDM 3D Printing of Crystalline Poorly Soluble Drug Loaded Filaments.在载有结晶性难溶性药物的长丝的熔融沉积成型3D打印过程中,通过融合辅助非晶化实现增强的过饱和度。
Pharmaceutics. 2021 Nov 4;13(11):1857. doi: 10.3390/pharmaceutics13111857.
2
A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.低温熔融沉积成型 3D 打印技术用于制造患者专用的即释片剂。
Pharm Res. 2016 Nov;33(11):2704-12. doi: 10.1007/s11095-016-1995-0. Epub 2016 Aug 9.
3
Exploring tablet design options for tailoring drug release and dose via fused deposition modeling (FDM) 3D printing.探索通过熔融沉积建模(FDM)3D 打印定制药物释放和剂量的片剂设计方案。
Int J Pharm. 2020 Dec 15;591:119987. doi: 10.1016/j.ijpharm.2020.119987. Epub 2020 Oct 16.
4
Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.用于片剂 3D 打印的聚己内酯热熔挤出纤维的制备及表征。
Eur J Pharm Sci. 2021 Mar 1;158:105619. doi: 10.1016/j.ejps.2020.105619. Epub 2020 Oct 25.
5
Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.快速溶解的熔融沉积成型3D打印片剂开发中的挑战、现状及新兴策略:综述与评论
ADMET DMPK. 2023 Jan 1;11(1):33-55. doi: 10.5599/admet.1622. eCollection 2023.
6
3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.3D 打印制药口服固体制剂的熔融沉积法:使用增塑 HPMCAS 提高可印刷性。
Int J Pharm. 2022 Mar 25;616:121553. doi: 10.1016/j.ijpharm.2022.121553. Epub 2022 Feb 5.
7
3D printing of immediate-release tablets containing olanzapine by filaments extrusion.通过丝状挤出法3D打印含奥氮平的速释片剂
Drug Dev Ind Pharm. 2021 Aug;47(8):1200-1208. doi: 10.1080/03639045.2021.1879833. Epub 2021 Feb 1.
8
Improving drug release rate, drug-polymer miscibility, printability and processability of FDM 3D-printed tablets by weak acid-base interaction.通过酸碱弱相互作用提高 FDM 3D 打印片剂的药物释放速率、药物-聚合物混溶性、可印刷性和可加工性。
Int J Pharm. 2023 Feb 5;632:122542. doi: 10.1016/j.ijpharm.2022.122542. Epub 2022 Dec 22.
9
Feasibility of high melting point hydrochlorothiazide processing via cocrystal formation by hot melt extrusion paired fused filament fabrication as a 3D-printed cocrystal tablet.热熔挤出联合熔融沉积制造作为一种 3D 打印共晶片剂,通过共晶形成将高熔点氢氯噻嗪加工成共晶的可行性。
Int J Pharm. 2022 Nov 25;628:122283. doi: 10.1016/j.ijpharm.2022.122283. Epub 2022 Oct 13.
10
Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.熔融沉积建模的快速药物释放 3D 打印片剂的配方:用于药物释放、药物-聚合物混溶性和可印刷性筛选的聚合物。
J Pharm Sci. 2018 Jan;107(1):390-401. doi: 10.1016/j.xphs.2017.10.021. Epub 2017 Oct 21.

引用本文的文献

1
Novel Strategies for the Formulation of Poorly Water-Soluble Drug Substances by Different Physical Modification Strategies with a Focus on Peroral Applications.通过不同物理改性策略制备难溶性药物的新策略,重点关注口服应用。
Pharmaceuticals (Basel). 2025 Jul 23;18(8):1089. doi: 10.3390/ph18081089.
2
Thermo-Structural Characterization of Phase Transitions in Amorphous Griseofulvin: From Sub-T Relaxation and Crystal Growth to High-Temperature Decomposition.非晶态灰黄霉素相变的热结构表征:从亚-T 弛豫和晶体生长到高温分解
Molecules. 2024 Mar 28;29(7):1516. doi: 10.3390/molecules29071516.
3
3D printing of amorphous solid dispersions: A comparison of fused deposition modeling and drop-on-powder printing.

本文引用的文献

1
Disparities of Single-Particle Growth Rates in Buried Versus Exposed Ritonavir Crystals within Amorphous Solid Dispersions.无定形固体分散体中埋藏与暴露利托那韦晶体中单颗粒生长速率的差异。
Mol Pharm. 2020 Dec 7;17(12):4564-4571. doi: 10.1021/acs.molpharmaceut.0c00744. Epub 2020 Nov 5.
2
Exploring tablet design options for tailoring drug release and dose via fused deposition modeling (FDM) 3D printing.探索通过熔融沉积建模(FDM)3D 打印定制药物释放和剂量的片剂设计方案。
Int J Pharm. 2020 Dec 15;591:119987. doi: 10.1016/j.ijpharm.2020.119987. Epub 2020 Oct 16.
3
Effect of solvents and cellulosic polymers on quality attributes of films loaded with a poorly water-soluble drug.
无定形固体分散体的3D打印:熔融沉积成型与粉末床熔融打印的比较
Int J Pharm X. 2023 Mar 20;5:100179. doi: 10.1016/j.ijpx.2023.100179. eCollection 2023 Dec.
4
3D printed matrix solid forms: Can the drug solubility and dose customisation affect their controlled release behaviour?3D打印基质固体剂型:药物溶解度和剂量定制会影响其控释行为吗?
Int J Pharm X. 2022 Dec 23;5:100153. doi: 10.1016/j.ijpx.2022.100153. eCollection 2023 Dec.
5
Dose Titration of Solid Dosage Forms via FDM 3D-Printed Mini-Tablets.通过熔融沉积成型(FDM)3D打印微型片剂对固体剂型进行剂量滴定
Pharmaceutics. 2022 Oct 27;14(11):2305. doi: 10.3390/pharmaceutics14112305.
6
Solid Dispersion Formulations by FDM 3D Printing-A Review.基于熔融沉积成型3D打印技术的固体分散体剂型——综述
Pharmaceutics. 2022 Mar 23;14(4):690. doi: 10.3390/pharmaceutics14040690.
7
Blind-Watermarking-Proof-of-Concept of a Novel Approach to Ensure Batch Traceability for 3D Printed Tablets.用于确保3D打印片剂批次可追溯性的新型方法的盲水印概念验证
Pharmaceutics. 2022 Feb 17;14(2):432. doi: 10.3390/pharmaceutics14020432.
溶剂和纤维素聚合物对载有难溶性药物的薄膜质量属性的影响。
Carbohydr Polym. 2020 Dec 15;250:117012. doi: 10.1016/j.carbpol.2020.117012. Epub 2020 Aug 29.
4
Manufacturing strategies to develop amorphous solid dispersions: An overview.开发无定形固体分散体的制造策略:综述。
J Drug Deliv Sci Technol. 2020 Feb;55. doi: 10.1016/j.jddst.2019.101459. Epub 2019 Dec 11.
5
Synergistic and antagonistic effects of various amphiphilic polymer combinations in enhancing griseofulvin release from ternary amorphous solid dispersions.各种两亲性聚合物组合在增强三元无定形固体分散体中灰黄霉素释放方面的协同和拮抗作用。
Eur J Pharm Sci. 2020 Jul 1;150:105354. doi: 10.1016/j.ejps.2020.105354. Epub 2020 May 4.
6
Amorphous solid dispersions containing residual crystallinity: Influence of seed properties and polymer adsorption on dissolution performance.含有残余结晶度的无定形固体分散体:晶种性质和聚合物吸附对溶解性能的影响。
Eur J Pharm Sci. 2020 Apr 15;146:105276. doi: 10.1016/j.ejps.2020.105276. Epub 2020 Feb 21.
7
Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release.利用聚乙烯醇作为聚合基质的熔融沉积成型法制备 3D 打印片剂以实现快速药物释放。
J Pharm Sci. 2020 Apr;109(4):1558-1572. doi: 10.1016/j.xphs.2020.01.015. Epub 2020 Jan 29.
8
High Content Solid Dispersions for Dose Window Extension: A Basis for Design Flexibility in Fused Deposition Modelling.高含量固体分散体用于扩展剂量窗口:熔融沉积建模中设计灵活性的基础。
Pharm Res. 2019 Dec 17;37(1):9. doi: 10.1007/s11095-019-2720-6.
9
Impact of Processing Parameters on the Quality of Pharmaceutical Solid Dosage Forms Produced by Fused Deposition Modeling (FDM).加工参数对熔融沉积成型(FDM)制备的药物固体剂型质量的影响
Pharmaceutics. 2019 Nov 27;11(12):633. doi: 10.3390/pharmaceutics11120633.
10
Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions.通过无定形固体分散体来挖掘抗癌药物的治疗潜力。
Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188319. doi: 10.1016/j.bbcan.2019.188319. Epub 2019 Oct 31.